Centre Muraz: Clinical Trials

6 trials sponsored by Centre Muraz, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 unknown. 6 Phase 2, 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 26Completed 4, Unknown 2
Phase 33Completed 2, Unknown 1

Follow Centre Muraz: new trials by email

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Early Treatment of Vulnerable Individuals With Non-Severe SARS-CoV-2 Infection
Nitazoxanide and Ciclésonide, Telmisartan 20Mg Oral Tablet, Paracetamol - Covid19, Covid19 Drug Treatment
Phase 2 / Phase 3UnknownANRS, Emerging Infectious Diseases6002021-04-122023-01-31
Preventing Childhood HIV: Rescue Intervention. ANRS 12388 PREVENIR-PEV
Lamivudine Oral Solution - HIV-1
Phase 2UnknownANRS, Emerging Infectious Diseases972019-12-042022-03-31
African-Canadian Study of HIV-Infected Adults and a Vaccine for Ebola - ACHIV-Ebola
V920 (rVSVΔG-ZEBOV-GP) Ebola Virus Vaccine, Saline - Ebola
Phase 2CompletedCanadian Immunization Research Network2512017-08-012026-01-12
Safety, Tolerability and Immunogenicity Study of 3 Prime-boost Regimens for Ebola Vaccines Ad26.ZEBOV/MVA-BN-Filo in Healthy Adults, Children and Human Immunodeficiency Virus Positive (HIV+) Adults
Ad26.ZEBOV, MVA-BN-Filo, Placebo - Hemorrhagic Fever, Ebola
Phase 2CompletedJanssen Vaccines & Prevention B.V.10752015-11-062022-03-07
Repeat Ivermectin Mass Drug Administrations for Control of Malaria: a Pilot Safety and Efficacy Study
Ivermectin, Albendazole - Malaria, Lymphatic Filariasis
Phase 2 / Phase 3CompletedColorado State University27122015-06-012019-01-04
Pharmacokinetic of Mefloquine-Artesunate in Plasmodium Falciparum Malaria Infection in Pregnancy
Mefloquine-artesunate - Plasmodium Falciparum Malaria
Phase 2 / Phase 3CompletedInstitute of Tropical Medicine, Belgium482008-10-012010-09-14

Conditions studied

Hemorrhagic Fever, Ebola (2)  ·  Malaria (2)  ·  COVID-19 (1)  ·  Elephantiasis, Filarial (1)  ·  Hemorrhagic Fevers, Viral (1)  ·  Malaria, Falciparum (1)

Interventions

Acetaminophen (1)  ·  Albendazole (1)  ·  Ebola Vaccines (1)  ·  Fluoxetine (1)  ·  Ivermectin (1)  ·  Lamivudine (1)  ·  Sodium Chloride (1)  ·  Tablets (1)  ·  Telmisartan (1)  ·  nitazoxanide (1)

Countries

Burkina Faso (5)  ·  Canada (1)  ·  Côte d’Ivoire (1)  ·  Guinea (1)  ·  Kenya (1)  ·  Uganda (1)  ·  United States (1)

Top investigators

Brian D. Foy, PhD (1)  ·  Cecile Tremblay, MD (1)  ·  Philippe Van de Perre, MD, PhD (1)  ·  Roch K Dabire, PhD (1)  ·  Tinto Halidou, PhD (1)  ·  Umberto D'Alessandro, MD (1)

Results publications

PMID 24891429, PMID 30878222, PMID 32025570, PMID 33872801, PMID 34714820, PMID 35015777, PMID 36574985, PMID 38603720, PMID 39300364, PMID 42567171

NIH funding

2019 (1)